Log in

Start Your Membership Now

June 16, 2011 On June 16, 2011, the U.S. Food and Drug Administration (FDA) added a consumer warning about heart risks to Chantix (varenicline), which is marketed as a smoking cessation medication, after researchers found that Chantix users had a 72% higher risk of hospitalization for heart problems than non-users. In addition to this safety announcement, this risk will also be included on the Warnings and Precautions section of the Chantix physician labeling. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resource | June 16, 2011

FDA Drug Safety Announcement: Chantix May Increase The Risk of Certain Cardiovascular Adverse Events in Patients With Cardiovascular Disease

June 16, 2011 On June 16, 2011, the U.S. Food and Drug Administration (FDA) added a consumer warning about heart risks to Chantix (varenicline), which is marketed as a smoking cessation medication, after researchers found that Chantix users had a 72% higher risk of hospitalization for heart problems than non-users. In addition to this safety announcement, this risk will also be included on the Warnings and Precautions section of the Chantix physician labeling. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.